Literature DB >> 8701920

Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure.

W L Frankel1, D A Herold, T W Ziegler, R L Fitzgerald.   

Abstract

Patients with chronic renal failure (CRF) are at increased risk for myocardial events that are difficult to evaluate due to atypical symptoms and chronically elevated protein markers of cardiac damage. This study evaluated cardiac troponin T (cTnT), a sensitive marker of cardiac injury, in patients with CRF without myocardial infarction symptoms, and assessed potential causes for elevated cTnT. Blood was obtained from 38 patients with CRF immediately before hemodialysis and from 16 of them post-dialysis, from 21 peritoneal dialysis patients, 10 patients with CRF not on dialysis, 11 patients with cardiomyopathy, and 10 adolescent patients with CRF undergoing hemodialysis. Samples were analyzed for myoglobin, creatine kinase, creatine kinase isoenzyme-MB (CK-MB), lactate dehydrogenase, lactate dehydrogenase isoenzyme-1 (LD-1), and cTnT. Cardiac TnT was elevated in: 71% of patient with CRF undergoing hemodialysis with no significant differences between pre- and post-dialysis values, 57% of patients with CRF on peritoneal dialysis, 30% of patients with CRF without dialysis, 18% of patients with cardiomyopathy, and 20% of adolescent patients with CRF undergoing hemodialysis. Myoglobin was elevated in almost all patients with CRF undergoing hemodialysis and without dialysis, whereas CK-MB and LD-1 were rarely elevated. Cross-reacting dialyzable substances and myocardial stretch were not major causes for elevated cTnT. Until future studies clarify the etiology of elevated cTnT in patients with CRF, results should be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701920     DOI: 10.1093/ajcp/106.1.118

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value.

Authors:  Adnan Abaci; Eyup Ekici; Abdurrahman Oguzhan; Bulent Tokgoz; Cengiz Utas
Journal:  Clin Cardiol       Date:  2004-12       Impact factor: 2.882

2.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

3.  Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin T: a prospective survey over one year.

Authors:  François-Pierre Mongeon; Marc Dorais; Jacques Le Lorier; Daniel Froment; Elaine Letendre; Stéphane Rinfret
Journal:  Open Cardiovasc Med J       Date:  2009-06-24

4.  Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.

Authors:  Halima Resić; Selma Ajanović; Nihad Kukavica; Fahrudin Masnić; Aida Corić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

5.  Elevated troponin T concentrations in critically ill patients.

Authors:  Jacqueline M T Klein Gunnewiek; Joris J J P M van de Leur
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440

6.  Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis.

Authors:  David C Gaze; Paul O Collinson
Journal:  Open Heart       Date:  2014-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.